Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO).
- Disclosed ownership: 5.9%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 5.9% ownership in ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 5.9% | 3,158,265 | 0 | 3,158,265 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 5.9% | 3,158,265 | 0 | 3,158,265 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 3.2% | 1,722,175 | 0 | 1,722,175 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 2.7% | 1,436,090 | 0 | 1,436,090 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer |